Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Correlation Between Heart and Liver Iron Levels Measured by Mri T2* and Serum Ferritin in Patients With Β-Thalassemia Major Publisher



Taghizadeh Sarvestani R1 ; Moradveisi B2 ; Kompany F3 ; Ghaderi E4
Authors

Source: International Journal of Pediatrics Published:2016


Abstract

Background Transfusion-induced iron overload leads to many complications in patients with β-thalassemia major. This study aimed to compare the level of iron stored in the liver and heart measured by MRI T2 * with ferritin levels in these patients. Materials and Methods This study was done on 52 patients with β-thalassemia major aged 7 to 29 years. Serum ferritin level was checked and heart and liver MRI T2* operation was performed, then the liver and heart iron level measured by MRI T2 * was compared with serum ferritin levels. Results 150-180 cc/kg packed cells were received on average. The mean ± SD serum ferritin level was 2644.8±1988.3 ng/mL. The mean ± SD relaxation times in liver and heart MRI T2* were 4.39±5.8 and 26.59±10.62 millisecond, respectively. A negative significant correlation was found between serum ferritin levels and liver MRI T2* (P < 0.05, r= -0.374). However, no statistically significant association was observed between serum ferritin levels and heart MRI T2*(P > 0.05). Conclusion Since there was no correlation between serum ferritin levels and cardiac iron levels, accurate assessment of cardiac iron load using MRI T2* is necessary in patients with β-thalassemia major. Serum ferritin level is reliable for assessing liver iron levels.
Related Docs
View other Related Docs
1. Serum Ferritin Levels and Irregular Use of Iron Chelators Predict Liver Iron Load in Patients With Major Beta Thalassemia: A Cross-Sectional Study, Croatian Medical Journal (2019)
2. Relationship Between Serum Ferritin and Hemoglobin Levels Determined by Cardiac and Hepatic T2 Mri in Beta-Thalassemia Intermedia and Major Patients, Frontiers in Biology (2017)
3. Beta-Thalassemia Major and Myocardial Iron Overload: A Longitudinal Study With Magnetic Resonance Imaging, Cardiology Research and Practice (2024)
Experts (# of related papers)
View all Related Experts
Negar Omidi (2)
Amir Ali Hamidieh (2)
Other Related Docs
4. The Relationship of Myocardial and Liver T2*Values With Cardiac Function and Laboratory Findings in Transfusion-Dependent Thalassemia Major Patients: A Retrospective Cardiac Mri Study, Journal of Cardiovascular and Thoracic Research (2023)
5. Comparison of Iron Chelation Effects of Deferoxamine, Deferasirox, and Combination of Deferoxamine and Deferiprone on Liver and Cardiac T2* Mri in Thalassemia Maior, Caspian Journal of Internal Medicine (2017)
6. Risk Factors Associated With Heart Failure in Patients With Β-Thalassemia, Iranian Heart Journal (2022)
7. The Effect of Quercetin on Iron Overload and Inflammation in Β-Thalassemia Major Patients: A Double-Blind Randomized Clinical Trial, Complementary Therapies in Medicine (2019)
8. Renal Hemosiderosis Among Iranian Transfusion Dependent Β-Thalassemia Major Patients, International Journal of Hematology-Oncology and Stem Cell Research (2017)
9. Association Between Iron Deposition in Splenic,Hepatic and Myocardial Tissues Assessed by T2*Relaxometry Technique, Caspian Journal of Internal Medicine (2021)
10. The Association of Pro-Oxidant/Antioxidant Balance and Blood Parameters in Patients With Beta-Thalassemia Major: A Cross-Sectional Study, Blood Research (2023)
11. Two Trade Names of Deferasirox (Osveral® and Exjade®) in Reduction of Iron Overload Parameters in Major Betathalassemia Patients: A Randomized Open Labeled Clinical Trial, Caspian Journal of Internal Medicine (2022)
12. Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging, Annals of Nutrition and Metabolism (2017)
13. Guideline Guideline for the Diagnosis and Treatment of Diabetes Mellitus in Patients With Transfusion-Dependent Thalassemia, Iranian Journal of Blood and Cancer (2023)
14. Role of Feature Tracking Cardiac Magnetic Resonance Imaging in Early Detection of Cardiac Dysfunction in Β-Thalassemia Patients Recovered From Covid-19: A Cross-Sectional Study, Health Science Reports (2024)
15. Efficacy of Hepatic T2∗ Mri Values and Serum Ferritin Concentration in Predicting Thalassemia Major Classification for Hematopoietic Stem Cell Transplantation, Pediatric Transplantation (2015)
16. Apolipoproteins A1, B, and Other Prognostic Biochemical Cardiovascular Risk Factors in Patients With Beta-Thalassemia Major, Hematology (2016)
17. Comparison of the Effects of Deferasirox Film-Coated Tablets (Jadenu®) and Deferasirox Dispersible Tablets (Exjade®) in Patients With Beta Thalassemia Major: A Preliminary Report of the Effects on the Satisfaction, Convenience, Cardiac/Liver Mri T2*, Serum Ferritin Level, and Biochemical Profiles, Frontiers in Pharmacology (2024)
18. Analysis of Determinant Factors of Liver Fibrosis Progression in Ex-Thalassemic Patients, International Journal of Hematology (2021)
19. Introducing a New Histologic Scoring System for Iron Deposition in Liver of Thalassemic Patients, Compared With Atomic Absorption Spectrometry, Experimental and Toxicologic Pathology (2015)
20. Comparison of Leptin and Ferritin Levels in Beta-Thal-Assemia Major and Healthy Individuals, New Armenian Medical Journal (2024)